OCV-501

DRUG3 trials

Sponsors

Otsuka Pharmaceutical Co., Ltd.

Conditions

Acute Myeloid Leukemia

Phase 1

A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients

CompletedNCT01440920

Otsuka Pharmaceutical Co., Ltd.Acute Myeloid Leukemia

Start: 2011-09-30End: 2013-07-31Updated: 2021-03-08

Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)

CompletedNCT01475370

Otsuka Pharmaceutical Co., Ltd.Acute Myeloid Leukemia

Start: 2012-01-24End: 2016-12-22Updated: 2021-03-02

Phase 2

A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia

CompletedNCT01961882

Otsuka Pharmaceutical Co., Ltd.Acute Myeloid Leukemia

Start: 2013-10-31End: 2017-11-16Updated: 2021-03-26

Related Papers

Phase II Trial of a Peptide Vaccine, Ocv-501 in Elderly Patients with Acute Myeloid Leukemia

Blood2018-11-298 citations